Before we arrive in San Diego for #BIO2026, we asked David Craig, Chief Executive Officer of @sarcomatrix Therapeutics Corp., what drives him.
Learn more: https://t.co/8lvlSyEfL3
For years, BIO Partnering™ has been a huge draw to BIO International Convention for Michael Salgaller, Supervisory Specialist, Technology Analysis and Marketing Unit at the @NIH. This is his why.
Learn more and register: https://t.co/8lvlSyDHVv
U.S. leadership in early-stage drug development is increasingly threatened as other countries take deliberate steps to sharpen their competitive edge. BIO looks forward to utilizing these recommendations to strengthen America’s competitiveness and patients’ access to future therapies.
.@reaganudall just released a new report on strengthening early-stage drug development in the United States. BIO provided funding for the project. Read more: https://t.co/5NzRShJkw3
For Stephen Joyce, Chief Business Officer of @GamidaCellTx, #BIO2026 marks a milestone - their 10th year of BIO Partnering™ meetings. See what keeps them coming back.
Learn more and register: https://t.co/8lvlSyDHVv
At #BIO2026, BIO Partnering™ is on track to reach a record breaking 70,000+ meetings. https://t.co/ZpbgpvyMAd breaks down how attendees are using the highly popular system to connect with investors, partners, and collaborators before they even arrive in San Diego. Read more: https://t.co/WBJc1KZWmL
Start-Up Stadium at #BIO2026 is where the next generation of biotech takes the stage. Watch emerging companies pitch live and discover breakthrough innovations before the rest of the world does. Explore Start-Up Stadium: https://t.co/8lvlSyDHVv
Driven By Purpose: Ahead of #BIO2026, Christina Hartman, Executive Director, Head of U.S. Government Affairs at @orchard_tx, is driven by hope for her daughter Charlotte - and the belief that continued advances in biotech can bring hope to children living with ultra-rare conditions. #BIO2026
Learn more and register: https://t.co/Fp2jdXnllw
The #FightOfOurLives often starts with a single moment. For Katy Grainger, one small, seemingly harmless moment changed everything. Within 36 hours, she was in septic shock - fighting for her life against an antibiotic-resistant infection.
Katy’s journey is deeply personal. And it’s a reminder of what it means to fight - the persistent push for new options, new treatments, and new answers for the fight ahead.
Watch Katy’s story and see how American biotech is transforming lives and delivering hope to millions: https://t.co/zvvwh8L8UO
Preparedness cannot be built during an emergency. In a new @statnews op-ed, W. Craig Vanderwagen and Jennifer B. Alton - architects of the original Pandemic and All-Hazards Preparedness Act - make the case for why Congress must reauthorize PAHPA now and confirm leadership at both ASPR and the CDC. Read more: https://t.co/sBDqOI0Xlq
A new analysis from @MagnoliaAccess warns the U.S. biopharmaceutical ecosystem is at risk, with projections showing up to a 55% decline in drugs reaching the market over the next 20 years. See how changes in research funding, regulatory uncertainty, and drug pricing policies could affect the future of drug development.
Read the report: “The U.S. Biopharmaceutical Innovation Ecosystem at Risk: The 20-Year Threat to U.S. Innovation and Cures.” https://t.co/zvru5h7mWp
Ahead of #BIO2026, we asked Chris Rofidal, Senior Director of Health Policy and Pipeline Strategy at @UTHRMed, what he's driven by: "I'm driven by innovation... we have to have innovative products to get to our patients to change lives, to save lives." Learn more: https://t.co/Fp2jdXnllw
This week in https://t.co/ZpbgpvzkpL: Patient advocates, including the
@tigerlilycares, are praising @GovernorVA's veto of Prescription Drug Affordability Board (PDAB) legislation, marking the third time such a proposal has come before the Virginia Legislature in five years. BIO weighs in on what this decision means for the state and for patients: https://t.co/LcCABhOGhx
AI is transforming biotech - and the #BIO2026 AI Summit on Monday, June 22 is where industry tech experts will share real-world, concrete examples of how AI is being meaningfully implemented to accelerate drug discovery, improve R&D productivity, and enable new scientific approaches. Learn more: https://t.co/Fp2jdXnllw
Come to #BIO2026 with more than a badge - come with a calendar full of productive 1:1 meetings. BIO Partnering™ connects you to the people who can move your work forward. Start scheduling: https://t.co/8lvlSyDHVv
Michael Stocum, President and CEO of @bantampharma, is coming back to #BIO2026 to build on the relationships and progress made last year after participating in BIO Partnering™ - and to share what it means for the cancer patients his work will serve.
Learn more and register: https://t.co/Fp2jdXnllw
At BIO 2026, biotech innovators, partners, and advocates from around the globe will come together — united by an unwavering conviction to solve the impossible, push boundaries, and make lives better — because together, our industry and our mission are driven by purpose. #BIO2026 Register: https://t.co/Fp2jdXnllw